Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Rockwell Medical Inc Closes $40.3 Million Public Offering Of Common Stock


Monday, 20 May 2013 02:35pm EDT 

Rockwell Medical Inc announced that the closing of the sale of 13,196,721 common shares, including 1,721,311 shares of common to cover overallotments, at $3.05 per share in an underwritten public offering for an aggregate offering amount of approximately $40.3 million. The net proceeds from the offering, after commissions and other estimated offering expenses, were approximately $37.7 million. Rockwell Medical plans to use the net proceeds to fund SFP clinical trials and for other general corporate purposes. Chardan Capital Markets, LLC acted as the sole book-running manager for the offering. Summer Street Research Partners acted as lead manager for the offering. C&Co/PrinceRidge LLC acted as co-manager for the offering. 

Related Company News

Company Quote

9.25
-0.14 -1.49%
28 Aug 2014